𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiovascular and hormonal effects of pramipexole, a novel dopamine agonist.

✍ Scribed by Peters, G.R.; Francom, S.F.; Wright, C.E.

Book ID
110019636
Publisher
Nature Publishing Group
Year
1996
Tongue
English
Weight
153 KB
Volume
59
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHNO, a novel dopamine agonist, in anima
PHNO, a novel dopamine agonist, in animal models of parkinsonism
✍ Dr. William Koller; Gregory Herbster; John Gordon 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

PHNO, a naphthoxazine compound, was investigated in animal models of central dopaminergic activity. The drug in doses of 5-300 micrograms/kg when administered subcutaneously, or transdermally, induced stereotypic behavior in rats which was blocked by haloperidol but not by reserpine pretreatment. In

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications
✍ Andrew J. Holman; Robin R. Myers 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

## Abstract ## Objective To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patients with fibromyalgia. ## Methods In this 14‐week, single‐center, double‐blind, placebo‐controlled, parallel‐group, escalating‐dose trial, 60 patients with fibromyalgia were randomiz